Innovation Standardized – High Performance Surface Consumables for Bioseparation

Published on: 


Tuesday, September 20, 2022 at 11 AM EST During chromatographic analysis of complex biotherapeutics, analytes may contain electron-rich functional groups, which have an affinity to metal surfaces and may cause issues such as poor peak shape. Join our webinar to learn how Waters addresses these challenges.

Register Free

Event Overview:

During chromatographic analysis of complex biotherapeutics, analytes may contain phosphate, carboxylate, or other electron-rich functional groups. These groups have an affinity to metal surfaces. As a result, long passivation protocols are needed to eliminate poor peak shape and improve recovery.
To address these challenges, Waters has developed MaxPeak™ High Performance Surfaces (HPS) which provide a barrier to undesired metal surface interactions. In this technical seminar, HPS benefits in bioseparation applications will be reviewed:
- Improved monitoring of deamidation
- Ability to create platform SEC methods
- Improved sensitivity for intact and subunit protein analysis
- Improved analysis of sialylated and phosphorylated glycans

Key Learning Objectives:

· How and why certain analytes are lost to metal surfaces
· Limitations of existing solutions to address this problem
· The basics of MaxPeak Premier HPS Technology
· How MaxPeak Premier HPS Technology solves the challenge of non-specific adsorption for metal sensitive analytes in bioseparations
· The chromatographic and analytical advantages of MaxPeak Premier across multiple bioseparation applications

Who Should Attend:

· Biopharma Market
· Analytical Development Scientist
· Formulation Development Scientist
· Bioprocess Development Scientist
· Discovery/early Research Scientist
· QC Scientist or Technician


Nick Zampa, D. Eng
Principal Product Marketing Manager
Waters Corporation

Nick Zampa, D. Eng is a principal product marketing manager with the Chemistry Technology Center at Waters Corporation. Prior to joining Waters in 2019, Nick worked in a variety scientific and engineering roles in the biopharmaceutical and clinical diagnostic industries. Roles included formulation scientist for biotherapeutic drug products, product development scientist for antibody-based reagents, and engineer for drug/device combination products. Nick holds an M.S. in Biology/Biotechnology and Doctor of Engineering in Engineering Management.

Register Free